Table 1 Characterization of patients

Patients (n)

10

Age (years)

59.3 ± 3.4

Sex (female/male)

8/2

Disease duration (years)

22.7 ± 3.2

C-reactive protein (mg/dl)

1.2 ± 0.4

DAS28-ESR

2.6 ± 0.4

Methotrexate (mg/week)

7.4 ± 1.4

Methylprednisolone (mg)

3.7 ± 0.9

 Adalimumab

2/10

 Tocilizumab

2/10

 Tacrolimus

2/10 (2, 1.5 mg)

 Etanercept

2/10

 Infliximab

1/10

 None

2/10